Global Nutrigenomics Market to Reach $2.5 Billion by 2030

New York, April 26, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nutrigenomics Industry" - https://www.reportlinker.com/p06032356/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Nutrigenomics Market to Reach $2.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Nutrigenomics estimated at US$715 Million in the year 2022, is projected to reach a revised size of US$2.5 Billion by 2030, growing at aCAGR of 17% over the period 2022-2030. Reagents & Kits, one of the segments analyzed in the report, is projected to record 18.1% CAGR and reach US$1.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 14.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $209.2 Million, While China is Forecast to Grow at 16% CAGR

The Nutrigenomics market in the U.S. is estimated at US$209.2 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$421.9 Million by the year 2030 trailing a CAGR of 16% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.7% and 13.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.8% CAGR.

Select Competitors (Total 33 Featured)
- BASF SE
- Cell-Logic
- Cura Integrative Medicine
- Geneus Health, LLC
- Genova Diagnostics
- GX Sciences, Inc.
- Koninklijke DSM N.V.
- Metagenics, Inc.
- Nutrigenomix
- NutriProCan
- Orig3n
- Prenetics Limited
- Seven Oaks General Hospital, part of Winnipeg Regional Health Authority
- The Gene Box
- Unilever
- Xcode Life


Read the full report: https://www.reportlinker.com/p06032356/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Nutrigenomics - Global Key Competitors Percentage Market Share
in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Nutrigenomics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 2: World Historic Review for Nutrigenomics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Nutrigenomics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Reagents & Kits by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 5: World Historic Review for Reagents & Kits by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 6: World 16-Year Perspective for Reagents & Kits by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 8: World Historic Review for Services by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Obesity by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 11: World Historic Review for Obesity by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Obesity by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Cancer Research by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 14: World Historic Review for Cancer Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 15: World 16-Year Perspective for Cancer Research by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Cardiovascular Diseases by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 17: World Historic Review for Cardiovascular Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 18: World 16-Year Perspective for Cardiovascular Diseases
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 20: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 21: World 16-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 22: World Nutrigenomics Market Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
Nutrigenomics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2023 (E)
Table 23: USA Recent Past, Current & Future Analysis for
Nutrigenomics by Product - Reagents & Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 24: USA Historic Review for Nutrigenomics by Product -
Reagents & Kits and Services Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 25: USA 16-Year Perspective for Nutrigenomics by Product -
Percentage Breakdown of Value Sales for Reagents & Kits and
Services for the Years 2014, 2023 & 2030

Table 26: USA Recent Past, Current & Future Analysis for
Nutrigenomics by Application - Obesity, Cancer Research,
Cardiovascular Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 27: USA Historic Review for Nutrigenomics by Application -
Obesity, Cancer Research, Cardiovascular Diseases and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 28: USA 16-Year Perspective for Nutrigenomics by
Application - Percentage Breakdown of Value Sales for Obesity,
Cancer Research, Cardiovascular Diseases and Other Applications
for the Years 2014, 2023 & 2030

CANADA
Table 29: Canada Recent Past, Current & Future Analysis for
Nutrigenomics by Product - Reagents & Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 30: Canada Historic Review for Nutrigenomics by Product -
Reagents & Kits and Services Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 31: Canada 16-Year Perspective for Nutrigenomics by
Product - Percentage Breakdown of Value Sales for Reagents &
Kits and Services for the Years 2014, 2023 & 2030

Table 32: Canada Recent Past, Current & Future Analysis for
Nutrigenomics by Application - Obesity, Cancer Research,
Cardiovascular Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 33: Canada Historic Review for Nutrigenomics by
Application - Obesity, Cancer Research, Cardiovascular Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 34: Canada 16-Year Perspective for Nutrigenomics by
Application - Percentage Breakdown of Value Sales for Obesity,
Cancer Research, Cardiovascular Diseases and Other Applications
for the Years 2014, 2023 & 2030

JAPAN
Nutrigenomics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2023 (E)
Table 35: Japan Recent Past, Current & Future Analysis for
Nutrigenomics by Product - Reagents & Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 36: Japan Historic Review for Nutrigenomics by Product -
Reagents & Kits and Services Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 37: Japan 16-Year Perspective for Nutrigenomics by
Product - Percentage Breakdown of Value Sales for Reagents &
Kits and Services for the Years 2014, 2023 & 2030

Table 38: Japan Recent Past, Current & Future Analysis for
Nutrigenomics by Application - Obesity, Cancer Research,
Cardiovascular Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 39: Japan Historic Review for Nutrigenomics by
Application - Obesity, Cancer Research, Cardiovascular Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 40: Japan 16-Year Perspective for Nutrigenomics by
Application - Percentage Breakdown of Value Sales for Obesity,
Cancer Research, Cardiovascular Diseases and Other Applications
for the Years 2014, 2023 & 2030

CHINA
Nutrigenomics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2023 (E)
Table 41: China Recent Past, Current & Future Analysis for
Nutrigenomics by Product - Reagents & Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 42: China Historic Review for Nutrigenomics by Product -
Reagents & Kits and Services Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 43: China 16-Year Perspective for Nutrigenomics by
Product - Percentage Breakdown of Value Sales for Reagents &
Kits and Services for the Years 2014, 2023 & 2030

Table 44: China Recent Past, Current & Future Analysis for
Nutrigenomics by Application - Obesity, Cancer Research,
Cardiovascular Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 45: China Historic Review for Nutrigenomics by
Application - Obesity, Cancer Research, Cardiovascular Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 46: China 16-Year Perspective for Nutrigenomics by
Application - Percentage Breakdown of Value Sales for Obesity,
Cancer Research, Cardiovascular Diseases and Other Applications
for the Years 2014, 2023 & 2030

EUROPE
Nutrigenomics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2023 (E)
Table 47: Europe Recent Past, Current & Future Analysis for
Nutrigenomics by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2022 through 2030 and % CAGR

Table 48: Europe Historic Review for Nutrigenomics by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 49: Europe 16-Year Perspective for Nutrigenomics by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2014, 2023 & 2030

Table 50: Europe Recent Past, Current & Future Analysis for
Nutrigenomics by Product - Reagents & Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 51: Europe Historic Review for Nutrigenomics by Product -
Reagents & Kits and Services Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 52: Europe 16-Year Perspective for Nutrigenomics by
Product - Percentage Breakdown of Value Sales for Reagents &
Kits and Services for the Years 2014, 2023 & 2030

Table 53: Europe Recent Past, Current & Future Analysis for
Nutrigenomics by Application - Obesity, Cancer Research,
Cardiovascular Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 54: Europe Historic Review for Nutrigenomics by
Application - Obesity, Cancer Research, Cardiovascular Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 55: Europe 16-Year Perspective for Nutrigenomics by
Application - Percentage Breakdown of Value Sales for Obesity,
Cancer Research, Cardiovascular Diseases and Other Applications
for the Years 2014, 2023 & 2030

FRANCE
Nutrigenomics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2023 (E)
Table 56: France Recent Past, Current & Future Analysis for
Nutrigenomics by Product - Reagents & Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 57: France Historic Review for Nutrigenomics by Product -
Reagents & Kits and Services Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 58: France 16-Year Perspective for Nutrigenomics by
Product - Percentage Breakdown of Value Sales for Reagents &
Kits and Services for the Years 2014, 2023 & 2030

Table 59: France Recent Past, Current & Future Analysis for
Nutrigenomics by Application - Obesity, Cancer Research,
Cardiovascular Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 60: France Historic Review for Nutrigenomics by
Application - Obesity, Cancer Research, Cardiovascular Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 61: France 16-Year Perspective for Nutrigenomics by
Application - Percentage Breakdown of Value Sales for Obesity,
Cancer Research, Cardiovascular Diseases and Other Applications
for the Years 2014, 2023 & 2030

GERMANY
Nutrigenomics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Germany for 2023 (E)
Table 62: Germany Recent Past, Current & Future Analysis for
Nutrigenomics by Product - Reagents & Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 63: Germany Historic Review for Nutrigenomics by Product -
Reagents & Kits and Services Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 64: Germany 16-Year Perspective for Nutrigenomics by
Product - Percentage Breakdown of Value Sales for Reagents &
Kits and Services for the Years 2014, 2023 & 2030

Table 65: Germany Recent Past, Current & Future Analysis for
Nutrigenomics by Application - Obesity, Cancer Research,
Cardiovascular Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 66: Germany Historic Review for Nutrigenomics by
Application - Obesity, Cancer Research, Cardiovascular Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 67: Germany 16-Year Perspective for Nutrigenomics by
Application - Percentage Breakdown of Value Sales for Obesity,
Cancer Research, Cardiovascular Diseases and Other Applications
for the Years 2014, 2023 & 2030

ITALY
Table 68: Italy Recent Past, Current & Future Analysis for
Nutrigenomics by Product - Reagents & Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 69: Italy Historic Review for Nutrigenomics by Product -
Reagents & Kits and Services Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 70: Italy 16-Year Perspective for Nutrigenomics by
Product - Percentage Breakdown of Value Sales for Reagents &
Kits and Services for the Years 2014, 2023 & 2030

Table 71: Italy Recent Past, Current & Future Analysis for
Nutrigenomics by Application - Obesity, Cancer Research,
Cardiovascular Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 72: Italy Historic Review for Nutrigenomics by
Application - Obesity, Cancer Research, Cardiovascular Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 73: Italy 16-Year Perspective for Nutrigenomics by
Application - Percentage Breakdown of Value Sales for Obesity,
Cancer Research, Cardiovascular Diseases and Other Applications
for the Years 2014, 2023 & 2030

UNITED KINGDOM
Nutrigenomics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United Kingdom for 2023 (E)
Table 74: UK Recent Past, Current & Future Analysis for
Nutrigenomics by Product - Reagents & Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 75: UK Historic Review for Nutrigenomics by Product -
Reagents & Kits and Services Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 76: UK 16-Year Perspective for Nutrigenomics by Product -
Percentage Breakdown of Value Sales for Reagents & Kits and
Services for the Years 2014, 2023 & 2030

Table 77: UK Recent Past, Current & Future Analysis for
Nutrigenomics by Application - Obesity, Cancer Research,
Cardiovascular Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 78: UK Historic Review for Nutrigenomics by Application -
Obesity, Cancer Research, Cardiovascular Diseases and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 79: UK 16-Year Perspective for Nutrigenomics by
Application - Percentage Breakdown of Value Sales for Obesity,
Cancer Research, Cardiovascular Diseases and Other Applications
for the Years 2014, 2023 & 2030

REST OF EUROPE
Table 80: Rest of Europe Recent Past, Current & Future Analysis
for Nutrigenomics by Product - Reagents & Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 81: Rest of Europe Historic Review for Nutrigenomics by
Product - Reagents & Kits and Services Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 82: Rest of Europe 16-Year Perspective for Nutrigenomics
by Product - Percentage Breakdown of Value Sales for Reagents &
Kits and Services for the Years 2014, 2023 & 2030

Table 83: Rest of Europe Recent Past, Current & Future Analysis
for Nutrigenomics by Application - Obesity, Cancer Research,
Cardiovascular Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 84: Rest of Europe Historic Review for Nutrigenomics by
Application - Obesity, Cancer Research, Cardiovascular Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 85: Rest of Europe 16-Year Perspective for Nutrigenomics
by Application - Percentage Breakdown of Value Sales for
Obesity, Cancer Research, Cardiovascular Diseases and Other
Applications for the Years 2014, 2023 & 2030

ASIA-PACIFIC
Nutrigenomics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Asia-Pacific for 2023 (E)
Table 86: Asia-Pacific Recent Past, Current & Future Analysis
for Nutrigenomics by Product - Reagents & Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 87: Asia-Pacific Historic Review for Nutrigenomics by
Product - Reagents & Kits and Services Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 88: Asia-Pacific 16-Year Perspective for Nutrigenomics by
Product - Percentage Breakdown of Value Sales for Reagents &
Kits and Services for the Years 2014, 2023 & 2030

Table 89: Asia-Pacific Recent Past, Current & Future Analysis
for Nutrigenomics by Application - Obesity, Cancer Research,
Cardiovascular Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 90: Asia-Pacific Historic Review for Nutrigenomics by
Application - Obesity, Cancer Research, Cardiovascular Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 91: Asia-Pacific 16-Year Perspective for Nutrigenomics by
Application - Percentage Breakdown of Value Sales for Obesity,
Cancer Research, Cardiovascular Diseases and Other Applications
for the Years 2014, 2023 & 2030

REST OF WORLD
Table 92: Rest of World Recent Past, Current & Future Analysis
for Nutrigenomics by Product - Reagents & Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 93: Rest of World Historic Review for Nutrigenomics by
Product - Reagents & Kits and Services Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 94: Rest of World 16-Year Perspective for Nutrigenomics
by Product - Percentage Breakdown of Value Sales for Reagents &
Kits and Services for the Years 2014, 2023 & 2030

Table 95: Rest of World Recent Past, Current & Future Analysis
for Nutrigenomics by Application - Obesity, Cancer Research,
Cardiovascular Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 96: Rest of World Historic Review for Nutrigenomics by
Application - Obesity, Cancer Research, Cardiovascular Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 97: Rest of World 16-Year Perspective for Nutrigenomics
by Application - Percentage Breakdown of Value Sales for
Obesity, Cancer Research, Cardiovascular Diseases and Other
Applications for the Years 2014, 2023 & 2030

IV. COMPETITION
Read the full report: https://www.reportlinker.com/p06032356/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

              Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001